Blueprint Medicines Corp
BPMC129.460USD
+0.180+0.14%
終値 08/15, 16:00（ET）15分遅れの株価
8.36B時価総額
損失額直近12ヶ月PER
詳細情報 Blueprint Medicines Corp 企業名
Blueprint Medicines Corporation is a global precision therapy company that is inventing life-changing medicines in two areas of allergy/inflammation and oncology/hematology. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritinib) and GAVRETO (pralsetinib), to patients in the United States and Europe, and it is globally advancing multiple programs for systemic mastocytosis (SM), lung cancer, breast cancer and other genomically defined cancers, and cancer immunotherapy. Its pipelines also include Elenestinib (BLU-263) (KIT), AYVAKIT (avapritinib) (KIT), Wild-type KIT research program, GAVRETO (pralsetinib) (RET), BLU-945 (EGFR), BLU-525 (EGFR), BLU-451 (EGFR exon 20 insertions), BLU-222 (CDK2), AYVAKIT (PDGFRA), GAVRETO (RET), BLU-222 (CDK2) and BLU-852 (MAP4K1). It is developing elenestinib (BLU-263), an investigational, orally available, potent and highly selective KIT inhibitor, for the treatment of indolent SM and other mast cell disorders.
企業情報
企業コードBPMC
会社名Blueprint Medicines Corp
上場日Apr 30, 2015
最高経営責任者「CEO」Ms. Kathryn D (Kate) Haviland
従業員数649
証券種類Ordinary Share
決算期末Apr 30
本社所在地45 Sidney Street
都市CAMBRIDGE
証券取引所NASDAQ Global Select Consolidated
国United States of America
郵便番号02139
電話番号16173747580
ウェブサイトhttps://www.blueprintmedicines.com/
企業コードBPMC
上場日Apr 30, 2015
最高経営責任者「CEO」Ms. Kathryn D (Kate) Haviland
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Kathryn D (Kate) Haviland
Ms. Kathryn D (Kate) Haviland
President, Chief Executive Officer
President, Chief Executive Officer
73.23K
+22.22%
Dr. Fouad Namouni, M.D.
Dr. Fouad Namouni, M.D.
President - Research and Development
President - Research and Development
31.96K
+33.54%
Ms. Christina Rossi
Ms. Christina Rossi
Chief Operating Officer
Chief Operating Officer
19.39K
-19.00%
Mr. Percy H. Carter, Ph.D.
Mr. Percy H. Carter, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
16.43K
-13.93%
Mr. Michael Landsittel
Mr. Michael Landsittel
Chief Financial Officer
Chief Financial Officer
13.43K
-68.90%
Ms. Ariel Hurley, CPA
Ms. Ariel Hurley, CPA
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
11.89K
--
Mr. Michael J. Tolpa
Mr. Michael J. Tolpa
Director
Director
--
--
Ms. Debra Durso-Bumpus
Ms. Debra Durso-Bumpus
Chief People Officer
Chief People Officer
--
--
Dr. Philina Lee, Ph.D.
Dr. Philina Lee, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
--
-100.00%
Ms. Jenna Cohen
Ms. Jenna Cohen
Vice President and Head, Investor Relations
Vice President and Head, Investor Relations
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Kathryn D (Kate) Haviland
Ms. Kathryn D (Kate) Haviland
President, Chief Executive Officer
President, Chief Executive Officer
73.23K
+22.22%
Dr. Fouad Namouni, M.D.
Dr. Fouad Namouni, M.D.
President - Research and Development
President - Research and Development
31.96K
+33.54%
Ms. Christina Rossi
Ms. Christina Rossi
Chief Operating Officer
Chief Operating Officer
19.39K
-19.00%
Mr. Percy H. Carter, Ph.D.
Mr. Percy H. Carter, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
16.43K
-13.93%
Mr. Michael Landsittel
Mr. Michael Landsittel
Chief Financial Officer
Chief Financial Officer
13.43K
-68.90%
Ms. Ariel Hurley, CPA
Ms. Ariel Hurley, CPA
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
11.89K
--
収益内訳
通貨: USD更新時刻: Sun, Apr 6
通貨: USD更新時刻: Sun, Apr 6
FY2024Q3
FY2024Q2
FY2024Q1
事業別USD
会社名
収益
比率
Product revenue
128.18M
100.00%
Collaboration, license and other revenue
1.00K
0.00%
地域別USD
会社名
収益
比率
United States
113.13M
88.26%
Rest of the world
15.05M
11.74%
事業別
地域別
事業別USD
会社名
収益
比率
Product revenue
128.18M
100.00%
Collaboration, license and other revenue
1.00K
0.00%
株主
更新時刻: Wed, Aug 13
更新時刻: Wed, Aug 13
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.90%
T. Rowe Price Associates, Inc.
8.28%
BlackRock Institutional Trust Company, N.A.
7.29%
Avoro Capital Advisors LLC
5.95%
Wellington Management Company, LLP
4.75%
他の
63.83%
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.90%
T. Rowe Price Associates, Inc.
8.28%
BlackRock Institutional Trust Company, N.A.
7.29%
Avoro Capital Advisors LLC
5.95%
Wellington Management Company, LLP
4.75%
他の
63.83%
種類
株主統計
比率
Investment Advisor
53.49%
Investment Advisor/Hedge Fund
37.15%
Hedge Fund
10.67%
Research Firm
3.05%
Sovereign Wealth Fund
1.19%
Individual Investor
0.93%
Venture Capital
0.77%
Bank and Trust
0.67%
Pension Fund
0.60%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
701
68.81M
106.41%
-3.22M
2025Q1
702
71.75M
110.98%
-1.27M
2024Q4
657
69.17M
108.25%
-2.83M
2024Q3
644
67.12M
105.97%
-7.85M
2024Q2
622
68.23M
108.95%
-6.94M
2024Q1
615
67.81M
110.73%
-5.62M
2023Q4
612
65.87M
108.35%
-10.02M
2023Q3
602
66.47M
109.56%
-7.64M
2023Q2
614
65.78M
108.78%
-8.60M
2023Q1
625
65.63M
109.42%
-10.28M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
6.63M
10.25%
-134.36K
-1.99%
Mar 31, 2025
T. Rowe Price Associates, Inc.
5.35M
8.28%
-266.46K
-4.74%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
4.89M
7.57%
-106.17K
-2.12%
Mar 31, 2025
Avoro Capital Advisors LLC
3.85M
5.95%
+2.67M
+224.89%
Mar 31, 2025
Wellington Management Company, LLP
3.07M
4.75%
-1.21M
-28.22%
Mar 31, 2025
State Street Global Advisors (US)
2.68M
4.15%
+183.91K
+7.36%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.52M
2.35%
+32.55K
+2.18%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
1.30M
2.01%
+605.78K
+86.91%
Mar 31, 2025
Macquarie Investment Management
1.29M
1.99%
+27.92K
+2.22%
Mar 31, 2025
AllianceBernstein L.P.
1.20M
1.85%
+58.22K
+5.12%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Wed, Aug 6
更新時刻: Wed, Aug 6
銘柄名
比率
ProShares Merger ETF
3.21%
AltShares Event-Driven ETF
1.43%
ProShares Ultra Nasdaq Biotechnology
0.92%
Goldman Sachs Future Health Care Equity ETF
0.84%
Hypatia Women CEO ETF
0.73%
First Trust Mid Cap Growth AlphaDEX Fund
0.58%
iShares Russell 2000 Growth ETF
0.54%
WisdomTree BioRevolution Fund
0.49%
SoFi Next 500 ETF
0.45%
JPMorgan Fundamental Data Science Small Core ETF
0.43%
詳細を見る
ProShares Merger ETF
比率3.21%
AltShares Event-Driven ETF
比率1.43%
ProShares Ultra Nasdaq Biotechnology
比率0.92%
Goldman Sachs Future Health Care Equity ETF
比率0.84%
Hypatia Women CEO ETF
比率0.73%
First Trust Mid Cap Growth AlphaDEX Fund
比率0.58%
iShares Russell 2000 Growth ETF
比率0.54%
WisdomTree BioRevolution Fund
比率0.49%
SoFi Next 500 ETF
比率0.45%
JPMorgan Fundamental Data Science Small Core ETF
比率0.43%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
